Inventor
Patrick Lupardus
Inventor
San Francisco, CA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides25%
Y02ATechnologies for adaptation to climate change8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
PatentTitleYear
10,564,165Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information202010,047,158Anti-TIGIT antibodies and methods of use201810,017,572Anti-tigit antibodies and methods of use20189,908,931'Anti-hemagglutinin antibodies and methods of use'20189,598,481'Anti-hemagglutinin antibodies and methods of use'20179,284,365'Anti-hemagglutinin antibodies and methods of use'20169,067,979'Anti-hemagglutinin antibodies and methods of use'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2020Patents assigned to GENENTECH INC (7)· patent assignee history
2015–2020Based in San Francisco, CA, US· patent location history
2018Based in Redwood City, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 7 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 5 | 2015–2020 |
| Redwood City, California, US | 2 | 2018 |